Evolution of novel, orally efficacious renin inhibitors: A topographical design approach towards Aliskiren.

被引:0
|
作者
Maibaum, J [1 ]
机构
[1] Novartis Pharma AG, Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland
来源
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2003年 / 226卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
50-MEDI
引用
收藏
页码:U9 / U9
页数:1
相关论文
共 50 条
  • [41] A COMBINED SYNTHETIC AND COMPUTATIONAL APPROACH TOWARDS THE DESIGN OF NOVEL PYRROLIDINE SUBSTANCE-P INHIBITORS
    RIZZI, JP
    ONEILL, BT
    BUNDESMANN, MW
    DESAI, MC
    LOWE, JA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 91 - COMP
  • [42] Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors
    Iijima, Daisuke
    Sugama, Hiroshi
    Awai, Nobumasa
    Takahashi, Yoichi
    Togashi, Yuko
    Takebe, Tohru
    Xie, Jianshu
    Shen, Jingkang
    Ke, Ying
    Akatsuka, Hidenori
    Kawaguchi, Takayuki
    Takedomi, Kei
    Kashima, Akiko
    Nishio, Masashi
    Inui, Yosuke
    Yoneda, Hikaru
    Xia, Guangxin
    Iijima, Toru
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (08): : 1351 - 1357
  • [43] Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases
    Steinig, Arno G.
    Li, An-Hu
    Wang, Jing
    Chen, Xin
    Dong, Hanqing
    Ferraro, Caterina
    Jin, Meizhong
    Kadalbajoo, Mridula
    Kleinberg, Andrew
    Stolz, Kathryn M.
    Tavares-Greco, Paula A.
    Wang, Ti
    Albertella, Mark R.
    Peng, Yue
    Crew, Linda
    Kahler, Jennifer
    Kan, Julie
    Schulz, Ryan
    Cooke, Andy
    Bittner, Mark
    Turton, Roy W.
    Franklin, Maryland
    Gokhale, Prafulla
    Landfair, Darla
    Mantis, Christine
    Workman, Jen
    Wild, Robert
    Pachter, Jonathan
    Epstein, David
    Mulvihill, Mark J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (15) : 4381 - 4387
  • [44] Design and synthesis of potent, selective, and orally efficacious DPP4 inhibitors accelerated by high-throughput structural biology
    Gwaltney, Stephen L., II
    Aertgeerts, Kathleen
    Feng, Jun
    Kaldor, Stephen W.
    Kassel, Daniel B.
    Manuel, Melinda
    Navre, Marc
    Prasad, G. Sridhar
    Shi, Lihong
    Skene, Robert J.
    Stafford, Jeffrey A.
    Wallace, Mike
    Xu, Rongda
    Ye, Sheng
    Zhang, Zhiyuan
    Webb, David R.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [45] Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of spirocyclic piperidines
    Chen, Austin
    Aspiotis, Renee
    Campeau, Louis-Charles
    Cauchon, Elizabeth
    Chefson, Amadine
    Ducharme, Yves
    Falgueyret, Jean-Pierre
    Gagne, Sebastien
    Han, Yongxin
    Houle, Robert
    Laliberte, Sebastien
    Larouche, Guillaume
    Levesque, Jean-Francois
    Mckay, Dan
    Percival, David
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (24) : 7399 - 7404
  • [46] Novel approach of fragment-based lead discovery applied to renin inhibitors
    Tawada, Michiko
    Suzuki, Shinkichi
    Imaeda, Yasuhiro
    Oki, Hideyuki
    Snell, Gyorgy
    Behnke, Craig A.
    Kondo, Mitsuyo
    Tarui, Naoki
    Tanaka, Toshimasa
    Kuroita, Takanobu
    Tomimoto, Masaki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (22) : 6066 - 6074
  • [47] DESIGN AND SYNTHESIS OF AN ORALLY POTENT HUMAN RENIN INHIBITOR CONTAINING A NOVEL AMINO-ACID, CYCLOHEXYLNORSTATINE
    IIZUKA, K
    KAMIJO, T
    HARADA, H
    AKAHANE, K
    KUBOTA, T
    UMEYAMA, H
    KISO, Y
    JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1989, (21) : 1678 - 1680
  • [48] TOWARDS AN APPROACH TO INTEGRATE TECHNOLOGICAL EVOLUTION INTO PRODUCT DESIGN
    Chapuis, Yannick
    Demoly, Frederic
    Gomes, Samuel
    DESIGN FOR HARMONIES, VOL 1: DESIGN PROCESSES, 2013,
  • [49] Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an AT1-receptor blocker in hypertensive patients
    Gradman, AH
    Schmieder, RE
    Lins, RL
    Chiang, YT
    Bedigian, MP
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 108A - 108A
  • [50] ORALLY POTENT HUMAN RENIN INHIBITORS DERIVED FROM ANGIOTENSINOGEN TRANSITION-STATE - DESIGN, SYNTHESIS, AND MODE OF INTERACTION
    IIZUKA, K
    KAMIJO, T
    HARADA, H
    AKAHANE, K
    KUBOTA, T
    UMEYAMA, H
    ISHIDA, T
    KISO, Y
    JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) : 2707 - 2714